4th International Caparica Conference in Antibiotic Resistance 2021
14th – 17th June 2021 | Caparica | Portugal
Dear Colleagues and friends
It is with great pleasure that we announce the upcoming international conference on Antibiotic Resistance, to be held in the Caparica, Portugal on 14th – 17th June 2021.
In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary.
The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure.
Appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us to control totally this problem. In this conference an attempt has been made to present the latest research on possibilities to manage this question.
The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.
During diverse sessions, all aspects related to epidemiology of resistance in animal and zoonotic pathogens, mobile elements containing resistance genes, proteomics of antimicrobial resistance, emerging antimicrobial resistance mechanisms, control of resistant infections, antimicrobial resistance in animal pathogens and its exchange with humans, organizing antibiotic surveillance, policies to stimulate drug development and discovery and alternatives strategies to overcome the problem of antimicrobial resistance worldwide will be discussed.
J. L. Capelo
On behalf of the organizing and scientific committee
Karen Bush, PhD
Affiliation: Indiana University Bloomington (USA)
Title: Do We Still Need New Antibiotics to treat MDR Enterobacterales?
David Livermore, PhD
Affiliation: Norwich Medical School, University of East Anglia, Norwich (UK)
Title: No respite in the war: resistance to the newest antibiotics.
Patrice Courvalin, PhD
Affiliation: Department of Microbiology, Institut Pasteur (France)
Alessandra Carattoli, PhD
Affiliation: Faculty of Medicine and Farmacology, Sapienza University of Rome (Italy)
Title: Plasmids and the spread of antibiotic resistance.
Fernando Baquero, PhD
Affiliation: Department of Microbiology, Ramón y Cajal University Hospital (Spain)
Title: Ecological Coalescence of Intestinal Microbiota and Antibiotic Resistance.
John Elmerdahl Olsen, PhD
Affiliation: Department of Veterinary and Animal Sciences, University of Copenhagen (Denmark)
Title: Treatment with antibiotics – does it affect conjugative transfer of resistance plasmids?
Olga Lomovskaya, PhD
Affiliation: Senior Vice President, Discovery and Clinical Microbiology, Qpex Biopharma (USA)
Patrícia Poeta, PhD
Affiliation: University of Trás-os-Montes and Alto Douro, Vila Real (Portugal)
Title: Could COVID-19 lead to an increase in antimicrobial resistance?
Affiliation: Indiana University Bloomington (USA)
Title: How Pharma has Responded to the Explosion of New Beta-Lactamases
Christina Vandenbroucke-Grauls, PhD
Affiliation: Amsterdam University Medical Centers (The Netherlands)
Title: Clostridioides difficile infection: risk factors and new treatment modalities.
Richard Novick, PhD
Affiliation: Departments of Medicine and Microbiology, NYU School of Medicine, New York (USA)
Title: The ABD platform for non-antibiotic antibacterial therapeutics.
Title: Avaliable soon.
Tatiana Pinto, PhD
Affiliation: Federal University of Rio de Janeiro (Brazil)
Title: Increasing occurrence of multidrug-resistant bacteria colonization among pregnant women in Brazil after the onset of COVID-19 pandemic.
Fred Tenover, PhD
Affiliation: Scientific Affairs Cepheid (USA)
Title: Challenges of the genotypic detection of antimicrobial resistance for stewardship and infection control.
Emilia Caselli, PhD
Affiliation: University of Modena and Reggio Emilia (Italy)
Title: Triazolyl Boronic Acids: novel scaffolds for cross class beta-lactamase inhibition.
Matthias Tacke, PhD
Affiliation: University College Dublin (Ireland)
Title: SBC3 – A Novel Silver-Based Antibiotic Drug Candidate against Resistant Bacteria and Fungi.
Bruno Gonzalez-Zorn, DVM, PhD
Affiliation: Complutense University of Madrid (Spain)
Title: One Health, antimicrobial resistance, and mobile genetic elements.
Elisabeth Grohmann, PhD
Affiliation: Beuth University of Applied Sciences Berlin (Germany)
Title: Novel antimicrobial surface coatings inhibit growth of multi-resistant biofilm-forming pathogens.
Simonetta Grilli, PhD
Affiliation: Institute of Applied Sciences and Intelligent Systems (Italy)
Title: The Biofilm Electrostatic Test: a new platform for rapid evaluation of biofilm formation.
Dilip Shah, PhD
Affiliation: Donald Danforth Plant Science Center, St. Louis (USA)
Title: Plant antifungal peptides: Modes of action and biotech applications.
Mattias Larsson, PhD
Affiliation: Karolinska Institutet, Department of Global Public Health, Stockholm (Sweden)
Title: Admission Screening & Cohort Care decrease Carbapenem Resistant Enterobacteriaceae in Vietnamese Pediatric ICU’s.
Eric T. Harvill, PhD
Affiliation: Department of Infectious Diseases, University of Georgia, Athens (USA)
Title: Natural history, ecology and antibiotics in model respiratory and middle ear pathogens.
Title: Avaliable soon.
Dear Friend and Fellows,
This is to let you know that there are 10 grants available for masters and PhD students.
The grant covers: registration, all meals (breakfast, lunch and dinner), welcome and gala diner, coffee breaks and 100 euros in cash.
To apply tell your students to send:
Rules to apply:
1.- PhD students will have preference over Master students.
2.- Distance accounts for 50% of the points.
3.- CV accounts for the other 50% (articles, 35%, conference presentations, 10%, and other valuable contributions of the candidate, 5%)
- Rise of Antimicrobial Resistance and Epidemiology: Concerns on Pathogen Resistance and Public Health
- A public health approach to antimicrobial Resistance
- Genetics of antimicrobial resistance
- Proteomics of antimicrobial resistance
- The emergence of antimicrobial resistance in animals
- Antimicrobial resistance in animal pathogens and its exchange with humans
- How antimicrobial resistance may be affected by the use of antibiotics in food and agriculture
- Mechanisms of Antibacterial Resistance
- Organizing antibiotic surveillance
- Policies to stimulate drug development and discovery
- Alternative Strategies to overcome the problem of antimicrobial resistance worldwide
- Control of resistant infections
Hotel Aldeia dos Capuchos
Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of IC2AR 2021 is working with CHS
We look forward to seeing you soon.
With kindest regards
The BIOSCOPE Team